Guggenheim’s Jason Cassorla gave Cigna’s outlook a caffeine jolt, raising the target price to $388 while maintaining a “Buy” ...

Each of the six major national insurers turned a profit in the first quarter of 2025, though financial pressures related to ...

Express Scripts, Cigna, UnitedHealthcare, CVS Caremark and Optum Rx are among the payers that have added Yesintek to their ...

Cigna delivered a knockout first quarter in 2025, prompting Raymond James to boost its price target from $360 to $385. The ...

Shares of Cigna Group (CI) rose on Monday after announcing upbeat Q1 results. Analysts are optimistic about the company's growth and raised guidance.

The early results for stop-loss claims, or claims for catastrophic losses, are in line with the insurer's expectations, ...

On Friday, the company’s health services unit Evernorth unveiled new programs in a reliable growth area: helping payers ...

Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the ...

This report covers recent developments in the health sector, including proposed US federal budget cuts affecting scientific ...

The Trump administration proposes significant budget cuts impacting U.S. health spending, scientific research, and safety ...

May 2, 2025Cigna Corporation beats earnings expectations. Reported EPS is $6.74, expectations were $6.35. Operator: Ladies and gentlemen, thank you for standing by for The Sector Group's First Quarter ...

The Cigna Group reported a strong start to the year, with first-quarter 2025 revenues rising 14% to $65.5 billion.